The Patent Finder

Emergent Product Development Gaithersburg Inc.

Also on record
Records under this name other than the patents Emergent Product Development Gaithersburg Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.

Back to Emergent Product Development Gaithersburg Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,883,172Chemically modified peptides with improved immunogenicity
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,445,670Combinatorial Library Approach to Iminocyclitols with Biological Activity
Formerly held
Lapsed on the fee record
Ended May 21, 2025 · Medium confidence
Lapsed on the fee recordEnded May 21, 2025Medium confidence
US 9,403,818Antimicrobial 4-oxoquinolizines
Lapsed on the fee record
Ended Aug 2, 2024 · USPTO record
Lapsed on the fee recordEnded Aug 2, 2024USPTO record
US 7,645,456Vaccinia Virus Strains
Lapsed on the fee record
Ended Jan 12, 2022 · Medium confidence
Lapsed on the fee recordEnded Jan 12, 2022Medium confidence
US 7,115,270Smallpox Vaccine
Term ended
Ended no later than Aug 26, 2021 · Medium confidence
Term endedEnded no later than Aug 26, 2021Medium confidence
US 6,723,325Smallpox Vaccine
Term ended
Term ended May 7, 2021 · High confidence
Term endedTerm ended May 7, 2021High confidence
US 7,459,524Chlamydia protein, sequence and uses thereof
Formerly held
Lapsed on the fee record
Ended Dec 2, 2016 · USPTO record
Lapsed on the fee recordEnded Dec 2, 2016USPTO record
US 7,442,373Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax
Lapsed on the fee record
Ended Oct 28, 2016 · USPTO record
Lapsed on the fee recordEnded Oct 28, 2016USPTO record
US 7,438,909Immunization and treatment methods for anthrax
Lapsed on the fee record
Ended Oct 21, 2016 · USPTO record
Lapsed on the fee recordEnded Oct 21, 2016USPTO record
US 7,419,807Chlamydia protein, gene sequence and uses thereof
Lapsed on the fee record
Ended Sep 2, 2016 · USPTO record
Lapsed on the fee recordEnded Sep 2, 2016USPTO record
10 of 30 patents shown.
Pro members see all 30.
Pro members: see all 30 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited